I'm now keeping an eye on: The SmPC for Tecentriq 1,875 mg solution for injection

🏭Roche Products Limited

💊💉 #atezolizumab.

I will let you know if it changes.

🌐 https://www.medicines.org.uk/emc/product/15037/smpc

#Atezolizumab is now able to be given subcutaneously. Great for #cancer patients who have poor veins, or would prefer to get in and out of treatment faster.

This was first approved in the UK by the MHRA. It is not available in the US or EU yet.
#Research #ClinicalTrials

(Forgive me while I chuckle at the “subcutaneous arm” and “intravenous ARM”. I am tired so it’s very funny.)

https://www.onclive.com/view/subcutaneous-atezolizumab-approved-in-great-britain-for-all-intravenous-indications

L'NHS, il servizio sanitario nazionale britannico, ha introdotto un trattamento che riduce drasticamente il tempo necessario per somministrare una terapia oncologica: invece delle solite ore trascorse in ospedale, ora ci vogliono solo sette minuti. Questa nuova procedura potrebbe liberare risorse preziose per il sistema sanitario e offrire una soluzione più veloce ai pazienti.

#Atezolizumab #Cure #Cancro #InnovazioneMedica

https://www.futuroprossimo.it/2023/08/atezolizumab-iniezione-riduce-a-7-minuti-le-sedute-contro-il-cancro/

'7 minute cancer jab' sounds a bit of a marketing spin.

#OncoPharm #TootRx #oncology #Atezolizumab

But we will take any capacity gains we can!

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...

💊💉 #atezolizumab SmPC for Tecentriq 840 mg concentrate for solution for infusion Tecentriq 1,200 mg concentrate for solution for infusion has been updated with changes to sections 1. Name of the medicinal product; 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.6 Special prec ...